Skip to content

Post-Approval Study of the Tecnis® Toric IOL

Post-Approval Study of the Tecnis® Toric IOL, Models ZCT300 and ZCT400

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02566083
Enrollment
365
Registered
2015-10-01
Start date
2015-10-21
Completion date
2019-05-23
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

This study is a prospective, multicenter, bilateral, non-randomized, open-label, comparative clinical study conducted at up to 80 sites in the USA. Subjects will choose to be bilaterally implanted with either 1) the TECNIS 1-Piece Toric IOLs, Model ZCT300 and/or ZCT400, or 2) the TECNIS Monofocal Model ZCB00 non-toric control IOL, according to subject preference

Interventions

DEVICEnon-toric intraocular lens

TECNIS One-piece Monofocal Model ZCB00

TECNIS One-piece Toric Models ZCT300 or ZCT400

Sponsors

Abbott Medical Optics
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Minimum 22 years of age * Bilateral cataracts * Preoperative keratometric cylinder in both eyes * Most appropriate toric IOL model choice (ZCT300 or ZCT400) * Predicted residual refractive cylinder, based on the AMO Toric IOL Calculator, must be: ≤ 0.69 D for a ZCT300 IOL or ≤ 0.88 D for a ZCT400 IOL * Clear intraocular media other than cataract in each eye * Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits * Ability to understand, read and write English in order to consent to study participation and complete a study questionnaire * Signed informed consent and HIPAA authorization

Exclusion criteria

* Irregular corneal astigmatism * Any corneal pathology/abnormality other than regular corneal astigmatism * Previous corneal surgery * Recent ocular trauma or intraocular surgery that is not resolved/stable or may affect visual outcomes * Any pupil abnormalities * Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects * Known ocular disease or pathology that may affect visual acuity or that may require surgical intervention during the course of the study * Concurrent participation or participation during 30 days prior to preoperative visit in any other clinical study * Planned monovision correction * Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes

Design outcomes

Primary

MeasureTime frameDescription
Rate of Severe Visual Distortions6 monthsThe rate of severe visual distortions under overall circumstances for the five visual distortion items of interest (lines that slant, tilt, split or separate; flat surfaces appearing curved; objects appearing further away or closer than they are; objects appearing to have a different size or shape; and physical discomfort related to vision). The six month data were used for this endpoint if available and if not an earlier visit was used. If a subject had a lens repositioning the questionnaire prior to the repositioning was used if available.

Countries

United States

Participant flow

Participants by arm

ArmCount
Toric IOL
Experimental (ZCT300, ZCT400)
214
Non-toric IOL
Control (ZCB00)
151
Total365

Baseline characteristics

CharacteristicNon-toric IOLTotalToric IOL
Age, Continuous69.7 Years
STANDARD_DEVIATION 10
69.5 Years
STANDARD_DEVIATION 9.75
69.3 Years
STANDARD_DEVIATION 9.6
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants29 Participants19 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
141 Participants336 Participants195 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants10 Participants6 Participants
Race (NIH/OMB)
Black or African American
18 Participants28 Participants10 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
128 Participants325 Participants197 Participants
Sex: Female, Male
Female
82 Participants202 Participants120 Participants
Sex: Female, Male
Male
69 Participants163 Participants94 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 2142 / 151
other
Total, other adverse events
0 / 2141 / 151
serious
Total, serious adverse events
32 / 21416 / 151

Outcome results

Primary

Rate of Severe Visual Distortions

The rate of severe visual distortions under overall circumstances for the five visual distortion items of interest (lines that slant, tilt, split or separate; flat surfaces appearing curved; objects appearing further away or closer than they are; objects appearing to have a different size or shape; and physical discomfort related to vision). The six month data were used for this endpoint if available and if not an earlier visit was used. If a subject had a lens repositioning the questionnaire prior to the repositioning was used if available.

Time frame: 6 months

Population: All subjects bilaterally implanted with a toric IOL (ZCT300 or ZCT400) and all subjects bilaterally implanted with a control IOL (ZCB00). All subjects who were monocularly implanted with a toric IOL (ZCT300/400) or control were excluded from the analysis.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Toric IOLRate of Severe Visual DistortionsWith No severe visual distortion189 Participants
Toric IOLRate of Severe Visual DistortionsWith severe visual distortion0 Participants
Non-toric IOLRate of Severe Visual DistortionsWith No severe visual distortion142 Participants
Non-toric IOLRate of Severe Visual DistortionsWith severe visual distortion2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026